Helen Torley
CIK 1528185 · PRESIDENT AND CEO · last filed 2026-07-09
Helen Torley is a PRESIDENT AND CEO who has filed 141 SEC Form 4 insider transactions across 5 companies since 2011. The most recent filing, for HALO, was dated Jul 9, 2026. Across all open-market trades the lifetime net is −$87.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $80.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$80.47M
5
141
-$87.82M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HALO | PRESIDENT AND CEO | 769,703 | $102.62 | $78.99M | -$153.4K | 1 | 2026-07-09 |
| HTI | PRESIDENT AND CEO | 767,780 | — | — | -$83.25M | 89 | 2026-06-03 |
| DGX | Director | 6,260 | $237.50 | $1.49M | $0 | 7 | 2021-05-25 |
| Relypsa Inc (RLYP) Delisted | Director | 0 | — | — | -$19.6K | 5 | 2016-09-02 |
| ONYX PHARMACEUTICALS INC (ONXX) Delisted | EVP, Chief Commercial Officer | 35,911 | — | — | -$4.40M | 14 | 2013-09-05 |
Recent Filings
141 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-09 | HALO | Mixed | — | -$130.2K | EDGAR |
| 2026-06-03 | HTI | Mixed | — | -$2.77M | EDGAR |
| 2026-05-13 | HTI | Mixed | — | -$2.83M | EDGAR |
| 2026-05-11 | HALO | Notice (144) | −101,923 | -$6.54M | EDGAR |
| 2026-04-07 | HTI | Mixed | — | -$514.3K | EDGAR |
| 2026-04-02 | HTI | Mixed | — | -$2.11M | EDGAR |
| 2026-03-04 | HTI | Mixed | — | -$2.87M | EDGAR |
| 2026-02-24 | HTI | Mixed | +18,049 | -$1.50M | EDGAR |
| 2026-02-17 | HTI | Mixed | +41,012 | -$3.82M | EDGAR |
| 2026-02-11 | HTI | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.